Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction.

Pende D, Castriconi R, Romagnani P, Spaggiari GM, Marcenaro S, Dondero A, Lazzeri E, Lasagni L, Martini S, Rivera P, Capobianco A, Moretta L, Moretta A, Bottino C.

Blood. 2006 Mar 1;107(5):2030-6. Epub 2005 Nov 22.

2.

The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.

El-Sherbiny YM, Meade JL, Holmes TD, McGonagle D, Mackie SL, Morgan AW, Cook G, Feyler S, Richards SJ, Davies FE, Morgan GJ, Cook GP.

Cancer Res. 2007 Sep 15;67(18):8444-9.

3.

Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112).

Pende D, Spaggiari GM, Marcenaro S, Martini S, Rivera P, Capobianco A, Falco M, Lanino E, Pierri I, Zambello R, Bacigalupo A, Mingari MC, Moretta A, Moretta L.

Blood. 2005 Mar 1;105(5):2066-73. Epub 2004 Nov 9.

4.

Tumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor.

Tahara-Hanaoka S, Shibuya K, Kai H, Miyamoto A, Morikawa Y, Ohkochi N, Honda S, Shibuya A.

Blood. 2006 Feb 15;107(4):1491-6. Epub 2005 Oct 25.

5.

Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule.

Bottino C, Castriconi R, Pende D, Rivera P, Nanni M, Carnemolla B, Cantoni C, Grassi J, Marcenaro S, Reymond N, Vitale M, Moretta L, Lopez M, Moretta A.

J Exp Med. 2003 Aug 18;198(4):557-67. Epub 2003 Aug 11.

6.

Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112).

Tahara-Hanaoka S, Shibuya K, Onoda Y, Zhang H, Yamazaki S, Miyamoto A, Honda S, Lanier LL, Shibuya A.

Int Immunol. 2004 Apr;16(4):533-8.

PMID:
15039383
7.

PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis.

Pende D, Bottino C, Castriconi R, Cantoni C, Marcenaro S, Rivera P, Spaggiari GM, Dondero A, Carnemolla B, Reymond N, Mingari MC, Lopez M, Moretta L, Moretta A.

Mol Immunol. 2005 Feb;42(4):463-9.

PMID:
15607800
8.

Identification and characterization of murine DNAM-1 (CD226) and its poliovirus receptor family ligands.

Tahara-Hanaoka S, Miyamoto A, Hara A, Honda S, Shibuya K, Shibuya A.

Biochem Biophys Res Commun. 2005 Apr 15;329(3):996-1000.

PMID:
15752754
9.

Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction.

Castriconi R, Dondero A, Corrias MV, Lanino E, Pende D, Moretta L, Bottino C, Moretta A.

Cancer Res. 2004 Dec 15;64(24):9180-4.

10.

DNAM-1 and PVR regulate monocyte migration through endothelial junctions.

Reymond N, Imbert AM, Devilard E, Fabre S, Chabannon C, Xerri L, Farnarier C, Cantoni C, Bottino C, Moretta A, Dubreuil P, Lopez M.

J Exp Med. 2004 May 17;199(10):1331-41. Epub 2004 May 10.

11.

NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection.

Draghi M, Pashine A, Sanjanwala B, Gendzekhadze K, Cantoni C, Cosman D, Moretta A, Valiante NM, Parham P.

J Immunol. 2007 Mar 1;178(5):2688-98.

12.

Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients.

Sanchez-Correa B, Gayoso I, Bergua JM, Casado JG, Morgado S, Solana R, Tarazona R.

Immunol Cell Biol. 2012 Jan;90(1):109-15. doi: 10.1038/icb.2011.15. Epub 2011 Mar 8.

PMID:
21383766
13.

DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK-T cell interaction.

Ardolino M, Zingoni A, Cerboni C, Cecere F, Soriani A, Iannitto ML, Santoni A.

Blood. 2011 May 5;117(18):4778-86. doi: 10.1182/blood-2010-08-300954. Epub 2011 Mar 15.

14.

NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor.

Vitale M, Della Chiesa M, Carlomagno S, Pende D, Aricò M, Moretta L, Moretta A.

Blood. 2005 Jul 15;106(2):566-71. Epub 2005 Mar 22.

15.

DNAM-1/CD155 interactions promote cytokine and NK cell-mediated suppression of poorly immunogenic melanoma metastases.

Chan CJ, Andrews DM, McLaughlin NM, Yagita H, Gilfillan S, Colonna M, Smyth MJ.

J Immunol. 2010 Jan 15;184(2):902-11. doi: 10.4049/jimmunol.0903225. Epub 2009 Dec 11.

16.

Analysis of NK cell/DC interaction in NK-type lymphoproliferative disease of granular lymphocytes (LDGL): role of DNAM-1 and NKp30.

Balsamo M, Zambello R, Teramo A, Pedrazzi M, Sparatore B, Scordamaglia F, Pende D, Mingari MC, Moretta L, Moretta A, Semenzato G, Vitale M.

Exp Hematol. 2009 Oct;37(10):1167-75. doi: 10.1016/j.exphem.2009.06.010. Epub 2009 Jul 4.

PMID:
19580844
17.

NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies.

Magri G, Muntasell A, Romo N, Sáez-Borderías A, Pende D, Geraghty DE, Hengel H, Angulo A, Moretta A, López-Botet M.

Blood. 2011 Jan 20;117(3):848-56. doi: 10.1182/blood-2010-08-301374. Epub 2010 Oct 28.

18.

Heterogeneous expression of the adhesion receptor CD226 on murine NK and T cells and its function in NK-mediated killing of immature dendritic cells.

Seth S, Georgoudaki AM, Chambers BJ, Qiu Q, Kremmer E, Maier MK, Czeloth N, Ravens I, Foerster R, Bernhardt G.

J Leukoc Biol. 2009 Jul;86(1):91-101. doi: 10.1189/jlb.1208745. Epub 2009 Apr 20.

PMID:
19380711
19.

Cutting edge: CD96 (tactile) promotes NK cell-target cell adhesion by interacting with the poliovirus receptor (CD155).

Fuchs A, Cella M, Giurisato E, Shaw AS, Colonna M.

J Immunol. 2004 Apr 1;172(7):3994-8.

20.

Reciprocal activating interaction between natural killer cells and dendritic cells.

Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchieri G.

J Exp Med. 2002 Feb 4;195(3):327-33.

Supplemental Content

Support Center